Forbes June 20, 2024
Arianna Johnson

Topline

Several medical spas and wellness centers are facing potential lawsuits from drugmaker Eli Lilly for allegedly selling compounded and counterfeit versions of ultra-popular weight loss and diabetes drugs Mounjaro and Zepbound, a problem also raised by Ozempic maker Novo Nordisk—and health organizations warn these products may pose serious side effects like infections.

Key Facts

How To Tell If Your Weight Loss Drugs Are Fake

There are several ways to spot fake GLP-1 drugs. Lilly noted some fake versions of its products have a pink hue instead of being colorless like the official products. If the product is labeled as generic tirzepatide or semaglutide then it’s fake because neither Lilly nor Novo Nordisk sells generic versions of its drugs. Another...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Seattle biotech startup Bonum upgrades offices, expands team in its pursuit of cancer drugs
Pfizer, Valneva inch closer to FDA approval of 1st Lyme disease vaccine
New Gene Therapy for Muscular Dystrophy May Facilitate Development of Others
Weight Loss Drugs’ Effects Could Be Improved by Priming Melanocortin System
J&J IRA pricing offer is in, as it sticks with 2025 guidance

Share This Article